Original news and analysis on international IP policy
A new report by two civil society groups explores what they say are discrepancies between European Union and provider country laws implementing the Nagoya Protocol on genetic resources, which they say could lead to legal uncertainties for users and providers.
The European Union and Canada held an informal meeting in Geneva this week to present a project for a multilateral investment court to handle global investor-state disputes, hoping to draw interest and questions by other country delegates, according to sources. Time will be needed to gain acceptance of the idea, they said, and the next opportunity will be at the January World Economic Forum in Davos.
The European Commission and the Canadian government today and tomorrow are hosting a first meeting for talks on a new multilateral investment court. Such a court could, the European Commission explained in an announcement, become the follow-up mechanism for the existing investor-state dispute settlement (ISDS) provisions that are part of 3,200 bilateral and multilateral free trade agreements around the world.
From extracurricular creativity to global campaigns, Universities Allied for Essential Medicines (UAEM) continues in its activities to raise awareness and explore how universities can best direct their research and innovations towards promoting global access to medicines. In the next year, UAEM will extend its national and international campaigns to address the high prices of medicines, continue to gather support for a global agreement on research and development and build on the mapping alternative R&D initiatives.
Veteran public health advocate Els Torreele of Belgium has been named the new executive director of the high-profile Médecins Sans Frontières (MSF, Doctors Without Borders) Access Campaign, based in Geneva.
According to the Centre for International Intellectual Property Studies, the proposed European Commission copyright reform is detrimental to authors' interests, and contrary to the objective of creating a single digital market.
A new register of intellectual property in the field of military and defence will soon be established in Russia in accordance with a recent decision of the national government, according to the state press service.
Thomas Cueni of Switzerland has been named the next director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), the Geneva-based organisation which represents the global research-based pharma industry.
The International Labour Organization Administration Tribunal (ILO-AT) on 30 November set aside two European Patent Office (EPO) decisions rejecting employee challenges to various internal rules. The judgments, which sent the complaints back to the EPO on the grounds that they had not been handled by the proper authorities, highlight the lack of a “fair and functioning” legal system for EPO staff, said an employee source who asked to remain anonymous.
Pfizer Board Chairman and CEO Ian Read has been elected as the next president of the Geneva-based International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), a two-year role.